Nature, Published online: 03 July 2024; doi:10.1038/d41586-024-02094-1
Structural insights into how anti-tuberculosis drugs interact with the enzyme that makes ATP in bacteria and humans pave the way for improved drug design to treat the disease and combat antimicrobial resistance.
Source link
